Abstract
To date, most of the Nanotechnology research has relied on the systemic delivery despite the low delivery efficiencies and benefits of the local and sustained delivery platforms. This prompt researchers to call the status quo treatment regimen into question and ask: Does Cancer Nanotechnology have a delivery problem? Nanotechnology can certainly deliver, but we need more efficient and sustained drug delivery platforms for cancer therapy.
How to Cite
Citation Information: João Conde, An analysis on Cancer Nanotherapy: does Nanotechnology have a delivery problem, Proceedings of the Nature Research Society, 2, 02001 (2018). doi: 10.11605/j.pnrs.201802001
History
Received: 15 September 2017, Accepted: 15 December 2017, Published Online: 01 January 2018
